A prospective observational study of a cohort of outpatients with an acute medical event and reduced mobility: Incidence of symptomatic thromboembolism and description of thromboprophylaxis practices

Journal of Internal Medicine

Volumn 260, Issue 2, 2006, Pages 168-176

  Bosson, J L ^a   Pouchain, D ^b   Bergmann, J F ^c  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b UFR Créteil   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Epidemiology; Low molecular weight heparin; Primary care; Prophylaxis; Venous thromboembolism incidence

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE DISEASE; ADULT; AGED; ANAMNESIS; ARTICLE; CLINICAL OBSERVATION; COHORT ANALYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FALLING; FAMILY HISTORY; FEMALE; FRANCE; GENERAL PRACTITIONER; HEPARINIZATION; HUMAN; INCIDENCE; INFECTION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT MOBILITY; PRIORITY JOURNAL; RANDOMIZATION; RHEUMATIC FEVER; RISK FACTOR; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; FAMILY PRACTICE; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOBILITY LIMITATION; PATIENT SELECTION; PROSPECTIVE STUDIES; RISK; THROMBOEMBOLISM; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 33745889609     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2006.01678.x     Document Type: Article

References (30)

1. Geerts WH, Pineo GF, Heit JA et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(Suppl. 3): 338S-400S.
2. White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost 2003; 90: 446-55.
3. Monreal M, Kakkar AK, Caprini JA et al. The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry. J Thromb Haemost 2004; 2: 1892-8.
4. Samama MM, Cohen AT, Darmon JY et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999; 341: 793-800.
5. Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ, PREVENT Medical Thromboprophylaxis Study Group. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004; 110: 874-9.
6. Cohen AT, Davidson BL, Gallus AS et al. Fondaparinux for the prevention of venous thromboembolism in acutely ill medical patients. Blood 2003; 102: abstract 42.
7. Leizorovicz A, Mismetti P. Preventing venous thromboembolism in medical patients. Circulation 2004; 110 (24 Suppl. 1): IV13-9.
8. Heit JA, Melton LJ 3rd, Lohse CM et al. Incidence of venous thromboembolism in hospitalized patients versus community residents. Mayo Clin Proc 2001; 76: 1102-10.
9. Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBO Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost 2000; 83: 657-60.
10. Thromboembolic Risk Factors (THRIFT) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ 1992; 305: 567-74.
11. Geerts WH, Heit JA, Clagett GP et al. Prevention of venous thromboembolism. Chest 2001; 119(Suppl. 1): 132S-75S.
12. International Consensus Statement. Prevention of thromboembolism. Int Angiol 1997; 16: 3-38.
13. Bergmann JF, Mouly S. Thromboprophylaxis in medical patients: focus on France. Semin Thromb Hemost 2002; 28 (Suppl. 3): 51-5.
14. Marshall RJ. Partitioning methods for classification and decision-making in medicine. Stat Med 1986; 5: 517-26.
15. Berlowitz DR, Ash AS, Hickey EC et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998; 339: 1957-63.
16. Cogo A, Bernardi E, Prandoni P et al. Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Intern Med 1994; 154: 164-8.
17. Bonifacj C, Quere I, Dupuy C, Janbon C, Daures JP. Case control studies of the risk factors for deep-vein thrombosis in an adult population hospitalized in internal medicine. Rev Epidemiol Sante Publique 1997; 45: 465-73.
18. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000; 160: 809-15.
19. Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 2000; 160: 3415-20.
20. Alikhan R, Cohen AT, Combe S et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med 2004; 164: 963-8.
21. Ageno W, Squizzato A, Ambrosini F et al. Thrombosis prophylaxis in medical patients: a retrospective review of clinical practice patterns. Haematologica 2002; 87: 746-50; discussion 250.
22. Bosson JL, Labarere J, Sevestre MA et al. Deep vein thrombosis in elderly patients hospitalized in subacute care facilities: a multicenter cross-sectional study of risk factors, prophylaxis, and prevalence. Arch Intern Med 2003; 163: 2613-8.
23. Tapson W, Decousus H, Bergmann JF et al. The International Medical Prevention Registry on Venous Thromboembolism (IMPROVE): Venous thromboembolism prophylaxis practices in acutely ill medical patients. Blood 2004; 104: abstract 1762.
24. Kucher N, Koo S, Quiroz R et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 2005; 352: 969-77.
25. Pouchain D, Bosson JL, Bergmann JF, Mansuy L. Risque thrombo-embolique veineux en ambulatoire. Résultats de l'étude DEPART (donnèes épidémiologiques chez les patients à risque thrombo-embolique). Rev Pract Med Gen 2003; 17: 116-20.
26. Vallano A, Arnau JM, Miralda GP, Perez-Bartoli J. Use of venous thromboprophylaxis and adherence to guideline recommendations: a cross-sectional study. Thromb J 2004; 2: 3.
27. Fagot JP, Flahault A, Kanfer A et al. Prevention of venous thromboembolism in a non-surgical medical ward. Proposed indications for low molecular weight heparin. Presse Med 2000; 29: 4-10.
28. Gatt ME, Paltiel O, Bursztyn M. Is prolonged immobilization a risk factor for symptomatic venous thromboembolism in elderly bedridden patients? Results of a historical-cohort study. Thromb Haemost 2004; 91: 538-43.
29. Wells PS, Owen C, Doucette S, Fergusson D, Tran H. Does this patient have deep vein thrombosis? JAMA 200; 295: 199-207.
30. Merli GJ. Pulmonary embolism in medical patients: improved diagnosis and the role of low-molecular-weight heparin in prevention and treatment. J Thromb Thrombolysis 2004; 18: 117-25.